Cargando…
Curcumin-Mediated HDAC Inhibition Suppresses the DNA Damage Response and Contributes to Increased DNA Damage Sensitivity
Chemo- and radiotherapy cause multiple forms of DNA damage and lead to the death of cancer cells. Inhibitors of the DNA damage response are candidate drugs for use in combination therapies to increase the efficacy of such treatments. In this study, we show that curcumin, a plant polyphenol, sensitiz...
Autores principales: | Wang, Shu-Huei, Lin, Pei-Ya, Chiu, Ya-Chen, Huang, Ju-Sui, Kuo, Yi-Tsen, Wu, Jen-Chine, Chen, Chin-Chuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4517890/ https://www.ncbi.nlm.nih.gov/pubmed/26218133 http://dx.doi.org/10.1371/journal.pone.0134110 |
Ejemplares similares
-
Dihydrocoumarin, an HDAC Inhibitor, Increases DNA Damage Sensitivity by Inhibiting Rad52
por: Chen, Chin-Chuan, et al.
Publicado: (2017) -
Targeting DNA Damage and Repair by Curcumin
por: Ji, Zhenyu
Publicado: (2010) -
Targeting HR Repair as a Synthetic Lethal Approach to Increase DNA Damage Sensitivity by a RAD52 Inhibitor in BRCA2-Deficient Cancer Cells
por: Tseng, Wei-Che, et al.
Publicado: (2021) -
HDAC-dependent decrease in histone crotonylation during DNA damage
por: Abu-Zhayia, Enas R, et al.
Publicado: (2019) -
HDAC1 dysregulation induces aberrant cell cycle and DNA damage in progress of TDP‐43 proteinopathies
por: Wu, Cheng‐Chun, et al.
Publicado: (2020)